Study of the Efficacy and Safety of Parsaclisib in Participants With Primary Warm Autoimmune Hemolytic Anemia
Clinical trial NCT05073458 · TERMINATED
Trial details
- NCT number
- NCT05073458
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-15
- Primary completion
- 2023-10-17
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.